Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Trial of Atorvastatin in p53-Mutant and p53 Wild-Type Malignancies

NCT03560882 is registered in ClinicalTrials.gov with Joaquina Baranda as lead sponsor.

NCT NCT03560882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03560882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Trial of Atorvastatin in p53-Mutant and p53 Wild-Type Malignancies
Lead sponsor
Joaquina Baranda
Phase
Phase 1
Overall status
Active, not recruiting
Start date
July 19, 2018
Completion date
August 1, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, cancer, malignant disease, myelodysplastic syndromes, relapsed hematologic malignancy, solid tumor